Saturday 17 October 2026 Export RIGL’s income statement to Excel — free account

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $294.3 million, up 64.1% from fiscal 2024. In the quarter to June 2026, revenue fell 22.6%, EPS fell 72.1%, free cash flow fell 230.0% and total debt fell 66.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

45.97 1.28 −2.71%

Follow RIGL

Alert me

Market cap: $882.6M
P/E: 2.6×
Fwd P/E: 7.9×
Dividend yield: —
F-score: 6/9
Altman Z: 2.70
Beneish M: 0.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	4.48	2.12	1.35	2.21
P/S ratio Full definition →		1.81	2.62	1.66	2.62
P/FCF ratio Full definition →		7.52	10.21	6.30	80.77
P/Operating CF Full definition →		21.26	35.05	182.70	23.66
P/B ratio Full definition →		4.35	1.97	1.25	1.71
Price to Tangible BV Full definition →		5.54	2.10	1.33	2.19
EV/Sales Full definition →		1.43	2.17	1.22	2.33
EV/EBITDA Full definition →		3.36	5.03	2.91	7.26
EV/Operating CF Full definition →		5.92	8.43	4.62	8.12
EV/FCF Full definition →		5.94	8.45	4.63	71.82
Quick Ratio Full definition →		1.94	2.08	2.20	1.58
Current Ratio Full definition →		2.28	2.42	2.62	1.94
Net Debt/EBITDA Full definition →		(3.75)	(5.63)	(10.70)	(3.91)
Debt/Assets Full definition →		12.36%	4.38%	2.97%	0.00%
Debt/Equity Full definition →		0.25	0.06	0.04	0.00
Asset Turnover Full definition →		1.48	0.87	0.88	0.76
Operating CF/Net income Full definition →		0.86	0.08	0.31	1.77
Capex/Depreciation Full definition →		(0.09)	0.00	0.00	(86.53)
Interest Coverage Full definition →		15.01	13.64	8.29	30.26
Research and Development Expense of Revenue Full definition →		10.59%	15.31%	19.85%	17.74%
Selling, General and Administrative Expense of Revenue Full definition →		41.66%	42.97%	52.11%	41.47%
Intangible Assets out of Total Assets Full definition →		0.10	0.05	0.05	0.18
Share Based Compensation of Revenue Full definition →		4.84%	3.94%	5.88%	8.70%
Graham Net Nets Full definition →		0.18	0.15	0.26	0.12
Graham Number Full definition →		30.47	99.56	99.04	95.51
Earnings Yield Full definition →		22.34%	47.26%	74.22%	45.17%
Free Cash Flow Yield Full definition →		13.30%	9.79%	15.88%	1.24%
Revenue per Share Full definition →		3.85	3.88	3.19	4.24
Operating CF per Share Full definition →		1.33	1.22	0.15	1.65
Capex per Share Full definition →		0.00	0.00	0.00	(3.79)
Free Cash Flow per Share Full definition →		1.33	1.22	0.15	(2.14)
Cash per Share Full definition →		7.60	8.61	7.97	5.14
Shareholders Equity per Share Full definition →		6.52	21.76	21.72	22.94
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		6.52	21.76	21.72	22.94
Free Cash Flow Full definition →		24.02	21.98	2.73	(39.69)
Working Capital Full definition →		120.53	140.93	144.54	89.94
Capital Expenditures Full definition →		(0.01)	—	—	(70.35)
Net Current Asset Value Full definition →		90.00	118.05	129.32	89.89
EV/EBIT Full definition →		3.40	5.08	2.94	7.41
Capex to Sales Full definition →		0.00	0.00	0.00	0.89
Price to Operating Income Full definition →		4.30	6.14	4.00	8.33
Other line items
Average Receivables Full definition →		38.25	46.69	45.75	47.97
Average Payables Full definition →		3.83	5.27	4.22	5.65
Average Inventory Full definition →		9.04	8.75	8.16	12.40
Average Assets Full definition →		190.98	338.79	340.29	363.90
Average Common Equity Full definition →		51.49	197.38	209.23	253.68

Fold the line items

Columns are period end dates

Stockrow Weekly